ZOLL Medical
Corporate Profile
ZOLL provides a comprehensive portfolio of medical devices and software solutions that diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. ZOLL became a member of the Asahi Kasei Group in April 2012 and is a global leader in acute critical care and related software and diagnostic tools. Through synergy with the other Healthcare businesses of Asahi Kasei, ZOLL helps advance emergency care and save lives, while increasing clinical and operational efficiencies.
| Trade name | ZOLL Medical Corporation |
|---|---|
| Main businesses | Developing and marketing medical devices and software solutions for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment |
| Home office | 269 Mill Rd., Chelmsford, MA 01824-4105 USA |
| CEO | Jonathan A. Rennert |
| Paid-in capital | US$1,723 million (including capital surplus) |
| Shareholder | Asahi Kasei Holdings US, Inc.* |
| Phone | +1-978-421-9655 |
(as of July 1, 2025)
- *Wholly owned subsidiary of Asahi Kasei Corp.
Officers & Directors
| Jonathan A. Rennert | Chief Executive Officer, Board Director |
|---|---|
| Ken Shinomiya | Board Director |
| Elijah A. White | Executive Officer President, ZOLL Acute Care Technology |
| Michael G. Blastick | Executive Officer President, ZOLL Cardiac Management Solutions |
| Collin S. Anderson | Executive Officer President, ZOLL Respicardia |
| Eric L. Knudsen | Executive Officer President, ZOLL Itamar |
| Craig M. Stowell | Executive Officer Chief Financial Officer |
| Aaron M. Grossman | Executive Officer Chief Legal Officer |
| Lynn A. Hersey | Executive Officer Vice President, Corporate Human Resources and Services |
| Jennifer R. Landis | Executive Officer Vice President, Corporate Development and Stategy |
(as of April 1, 2025)